Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease
Proyectos Europeos
Proyectos financiados por la Unión Europea
MyCyFAPP
H2020

Innovative approach for self-management and social welfare of cystic fi brosis patients in Europe: development, validation and implementation of a telematics tool
ImmunAID
H2020

Immunome project consortium for AutoInflammatory Disorders
FAST-Bact
H2020

A novel fast and automated kit for antibiotic susceptibility testing for Gram positive and negative bacteria
Colodetect
H2020

Development of a novel bloodbased diagnostic test for colorectal cancer.
BADGER
H2020

CalScreener® - an innovative device for bacterial analysis and diagnostics through growth and energy-release in real-time
NanoTBTech
H2020

Nanoparticles-based 2D thermal bioimaging technologies
EATRIS-Plus
H2020

Consolidating the capacities of EATRIS-ERIC for Personalised Medicine.
DECISION
H2020

Decompensated cirrhosis: identification of new combinatorial therapies based on system approaches
MON4STRAT
FP7

Therapeutic Beta-Lactams Monitoring for Stratified and dose adjusted treatment of hospital-acquired pneumonia: improved efficacy, decreased treatment length, and reduction of emergence of resistance
SENATOR
FP7

Development and clinical trials of a new Software ENgine for the Assessment & Optimization of drug and nondrug Therapy in Older peRsons
i-ABC
IMI / IHI

Inhaled antibiotics in bronchiectasias and cystic fibrosis.